Skip to main content
OpenTrials
Completed

NCT Number: NCT01145911

The Study of Ocular Hemodynamics With Glaucoma Progression

To determine the relationships between ocular hemodynamics and glaucomatous optic neuropathy progression.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Indiana University School of Medicine, Department of Ophthalmology

Indianapolis, Indiana, 46202, United States

About this study

  • To determine whether baseline ocular blood flow values are predictive of glaucomatous progression as determined by visual field analysis.
  • To determine how changes in ocular blood flow are related to visual field progression.
  • To determine how changes in ocular blood flow are related to changes in optic nerve structure and topographic change over time.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients will meet all of the following inclusion criteria to enter the study:

  • Age: 30 years or older.
  • Diagnosis: confirmed open-angle glaucoma in at least one eye:
  • glaucomatous visual field loss on Humphrey 24-2 or 10-2 perimetry
  • glaucomatous optic disc cupping
  • agreement between two baseline exams for reliability
  • Best corrected visual acuity at least 20/60 in at least one eye.
  • Prior Humphrey visual fields demonstrate acceptable reliability standards (see below).

Exclusion criteria

  • Extensive Humphrey visual field damage consisting of either a mean deviation (MD) < -15 decibels or a clinically determined threat to fixation in both hemifields.
  • Evidence of exfoliation or pigment dispersion.
  • History of acute angle-closure or a narrow, occludable anterior chamber angle by gonioscopy.
  • History of chronic or recurrent inflammatory eye diseases (e.g., scleritis, uveitis).
  • History or signs of intraocular trauma.
  • Severe or potentially progressive retinal disease such as retinal degeneration, diabetic retinopathy, and retinal detachment.
  • Any abnormality preventing reliable applanation tonometry.
  • Current use of any ophthalmic or systemic steroid which may interfere with this investigation.
  • Cataract surgery within the past year.
  • Resting pulse < 50 beats per minute.
  • Severe, unstable or uncontrolled cardiovascular, renal, or pulmonary disease.

Treatment and study plan

Primary outcomes

  1. Ocular Blood Flow

    Time frame: various

    per visit

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Registry information

Acronym: IGPS

Important dates

Study start
2008
Primary completion
2014
Study completion
2014
First posted
Jun 17, 2010
Registry last updated
Mar 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.